Sticky Proteins??? Alzheimer's, Parkinson's, and ALS...Dr. Maria Maccecchini, President & CEO, Annovis Bio

episode

BioTech Nation ... with Dr. Moira Gunn not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-23-2026 10PM EDT 4 min · 24 Sep 2026 · NPR News Now

10PM ET 09/23/2026 Newscast 3 min · 24 Sep 2026 · Fox News Hourly Update

Whateley in a Snapshot | Thursday (24.09.26) 6 min · 24 Sep 2026 · Whateley

The Great Vladdy Jr. Debate of 2026 Continues 39 min · 24 Sep 2026 · Blue Jays Talk

Xi Jinping meets Trump: who holds the cards? 29 min · 24 Sep 2026 · Today in Focus

Ross & Rizzo Unfiltered - Alex Bregman’s INJURY, White Sox PLAYOFF PUSH, Anthony Rizzo’s WILD Cubs playoff idea 1h 2m · 24 Sep 2026 · The Herd with Colin Cowherd

Report any issue

Source

Recorded28 Jun 2023

Publisherfeeds.transistor.fm ↗

Handlerec:13349856

Show notes

This week we explore the commonalities among neurodegenerative disorders such as Alzheimer's, Parkinson's, and ALS. Dr. Maria Macccecchini, Founder and CEO of Annovis Bio, discusses the role of sticky proteins in these diseases and how her company is developing a drug to prevent the aggregation of these proteins. The episode also touches on their ongoing clinical trials for Alzheimer's and Parkinson's and their potential application in treating traumatic brain injuries.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in